NINGDE, China, Aug. 10, 2025 /PRNewswire/ -- On August 10th, NING Service, an independent aftermarket brand under CATL, celebrated its first anniversary alongside the 10th...
NINGDE, China, Aug. 10, 2025 /PRNewswire/ -- On August 10th, NING Service, an independent aftermarket brand under CATL, celebrated its first anniversary alongside the 10th...
NINGDE, China, Aug. 10, 2025 /CNW/ -- On August 10th, NING Service, an independent aftermarket brand under CATL, celebrated its first anniversary alongside the 10th...
NINGDE, China, Aug. 10, 2025 /PRNewswire/ -- On August 10th, NING Service, an independent aftermarket brand under CATL, celebrated its first anniversary alongside the 10th...
LUXEMBOURG, Aug. 10, 2025 (GLOBE NEWSWIRE) -- Bitcoin Swift (BTC3), a decentralized financial operating system integrating programmable PoY (Proof of Yield) rewards, AI-powered smart contracts, decentralized identity, and a hybrid PoW plus PoS consensus, has announced the latest developments in its Stage 4 presale. The presale is currently priced at $4, with a planned launch price of $15, offering Stage 4 participants an APY of 106%.
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Folqs, a U.S.-based wellness company, introduces new consumer product, Folqs First-Day Colostrum Powder. This positions the company within the growing colostrum supplement sector, which has recently exceeded $3 billion in global market value, according to industry research.
The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...
The dynamics of the urothelial carcinoma market are anticipated to change due to the demand for innovative therapies, particularly in chemotherapy and immunotherapy, and...
The Biomarkers Market is anticipated to expand at a rapid pace due to the increasing demand for personalized medicine, rising prevalence of chronic and...
Fifth-Year Cohort of Scholars Selected from Nearly 400 Applicants Across 20 DPT Programs Nationwide
PHOENIX, Aug. 6, 2025 /PRNewswire/ -- Rizing Tide, a foundation dedicated to...
Is Increased Use of PGT-A Always Better? Experts Call for Evidence-Based Use of Mosaic EmbryosChoosing the Right PGT-A Platform: NUWA Fertility and Global Experts Unite...
Tokyo, Japan and Cambridge, UK, 6 August 2025 – Nxera Pharma Co., Ltd. (“Nxera”; TSE: 4565) a technology-powered biopharmaceutical company, today announces the launch of a broad new pipeline strategically focused on advancing next-generation therapies for obesity and associated metabolic disorders.